Evidence map›Paper›PMID 38029752›Full record

ArticleMolecular cell2023

A direct interaction between CPF and RNA Pol II links RNA 3' end processing to transcription.

Manuel Carminati, Juan B Rodríguez-Molina, M Cemre Manav, Dom Bellini, Lori A Passmore

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Manuel CarminatiMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
Juan B Rodríguez-MolinaMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
M Cemre ManavMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
Dom BelliniMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
Lori A PassmoreMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK. Electronic address: passmore@mrc-lmb.cam.ac.uk.
MRC Laboratory of Molecular Biology · GB

Funding

Medical Research Council MC_U105192715Medical Research Council MC_UP_1201/6Wellcome Trust
6 · The paper itself

Abstract

Transcription termination by RNA polymerase II (RNA Pol II) is linked to RNA 3' end processing by the cleavage and polyadenylation factor (CPF or CPSF). CPF contains endonuclease, poly(A) polymerase, and protein phosphatase activities, which cleave and polyadenylate pre-mRNAs and dephosphorylate RNA Pol II to control transcription. Exactly how the RNA 3' end processing machinery is coupled to transcription remains unclear. Here, we combine in vitro reconstitution, structural studies, and genome-wide analyses to show that yeast CPF physically and functionally interacts with RNA Pol II. Surprisingly, CPF-mediated dephosphorylation promotes the formation of an RNA Pol II stalk-to-stalk homodimer in vitro. This dimer is compatible with transcription but not with the binding of transcription elongation factors. Disruption of the dimerization interface in cells causes transcription defects, including altered RNA Pol II abundance on protein-coding genes, tRNA genes, and intergenic regions. We hypothesize that RNA Pol II dimerization may provide a mechanistic basis for the allosteric model of transcription termination.

Indexed as

RNA Polymerase IISaccharomyces cerevisiae ProteinsGenome-Wide Association StudyRNA 3' End ProcessingSaccharomyces cerevisiaeTranscription, GeneticRNA Polymerase IISaccharomyces cerevisiae ProteinsCPSFcryo-EMphosphatasepoly(A) tailpolymerasetranscriptionX-ray crystallography

Identifiers

PMID38029752
PMCPMC10783616
OpenAlexW4389083252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.